The management guided for ARV API & formulation demand to be normalised from Q4FY22 and reiterated the aspiration of US $ 1 billion in sales by FY23: ICICI Direct
Company to manufacture drug substance for clinical supply of HaemaLogiX’s lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facility in Guangzhou, China
The companies will continue with their exclusive agreements, including commercialization of their current portfolio
SOLOSEC is designed to be easy to take and one oral dose contains a complete course of treatment
The company develops sustainable botanical materials for agricultural and pharmaceutical applications
Cipla announced its unaudited consolidated financial results for quarter ended December 31st, 2021.
_256_384.jpg)
The oversubscribed round was led by New York-based HOF Capital and welcomed new investors including Headline, East Ventures, MS&AD Ventures, DG Daiwa Ventures, Pioneer Fund, as well as existing investor Insignia Ventures Partners
Astec LifeSciences has reported its financial performance for the quarter ended December 31, 2021
Companies plan to commercialize breath-based detection of lung infection and transplant rejection
The company has been manufacturing masks since the Covid-19 outbreak in 2020
Subscribe To Our Newsletter & Stay Updated
